EXAS vs MYSZ · rev $2.76B vs rev $5.5M
EXACT Sciences Corporation (EXAS) versus My Size Inc (MYSZ) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
My Size Inc (MYSZ) is a software - application company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MYSZ revenue for 2026-06-30 was $5.5M. Net income was -$3.2M. MYSZ currently screens at market cap $4.0M.
EXAS currently screens at market cap $20.03B. MYSZ currently screens at market cap $4.0M.
Not investment advice. Open the EXAS and MYSZ stock pages for the full models.
Not investment advice.